Hepatic Arterial Infusion Chemotherapy Combined Lenvatinib and PD-1 Inhibitor Showed Improved Survival for Infiltrative Hepatocellular Carcinoma: A Multicenter Cohort Study
Patient with infiltrative HCC, HAIC+Len+PD-1 treatment had longer OS and PFS than Len+PD-1 treatment. Early AFP response was an effective indicator of better survival and tumor response to therapy.
Authors
- Ruixia Li (ORCID: https://orcid.org/0000-0002-0179-1807)
- Murong Wang
- Xiaohui Wang (ORCID: https://orcid.org/0000-0003-0544-2599)
- Hui Li (ORCID: https://orcid.org/0000-0003-4938-1783)
- Juncheng Wang (ORCID: https://orcid.org/0000-0003-1696-1052)
- Qunfang Zhou (ORCID: https://orcid.org/0000-0002-2533-3851)
- Wei Wang (ORCID: https://orcid.org/0000-0002-3018-1629)
Institutions
- Sun Yat-sen University (CN)
- Chinese PLA General Hospital (CN)
- The First Affiliated Hospital, Sun Yat-sen University (CN)
- Sun Yat-sen University Cancer Center (CN)
- Hunan Provincial People's Hospital (CN)
- Jinzhou Medical University (CN)
Publication Details
- Journal
- Journal of Hepatocellular Carcinoma
- Published
- 2024-09-01
- DOI
- https://doi.org/10.2147/jhc.s477872
- Citations
- 5
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 1.85
Funders
- National Natural Science Foundation of China